CLINICAL_TRIALS
trial_result
· 2011-02-21
Clinical Trial Update: Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Advanced Or Metastatic Breast Cancer [Phase 2]
Summary
This Phase 2 trial compares pazopanib plus lapatinib against lapatinib alone in advanced or metastatic breast cancer, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Breast | Phase 2 | Status: COMPLETED | Results posted: 2011-02-21